TPP

1:39PM
Printer-friendly version

A trade deal has been struck with 11 countries on both sides of the Pacific, including Canada.


10:58AM
Printer-friendly version

For smaller countries, access to the U.S. market is a major prize.


3:05AM
Printer-friendly version

Donald Trump doesn’t understand the benefits of trade, and Hillary Clinton has criticized trade on the campaign trail.


7:51AM
Printer-friendly version
America has gone from being the world’s third most economically free country in 2000 to the 16th freest in 2014.

3:11AM
Printer-friendly version

Companies might relocate production capacity from the U.S. to Canada to gain duty-free access to the Chinese domestic market.


2:00AM
Printer-friendly version

Canada's lagging intellectual property (IP) protections for pharmaceutical innovators are a key issue to be settled in the Comprehensive Economic and Trade Agreement (CETA) negotiations with the European Union. They may also play a role in upcoming negotiations for the multi-country Trans-Pacific Partnership (TPP). Two new essays on the cost and benefits of stronger protection suggest Canadians would be far better off, in both economic and health terms, with an IP protection regime for pharmaceutical innovators that was more closely aligned with international standards.


2:00AM
Printer-friendly version

There are few Canadians who understand agricultural supply management and how it affects their daily lives, which is a major reason why this outdated system has survived. It’s receiving greater scrutiny now, though, because it’s impeding trade agreements.